UnitedHealth to Make Last Push for DOJ Blessing on Amedisys Deal

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to challenge their proposed tie-up, according to people familiar with the matter.

The high-stakes meeting between the companies and DOJ antitrust leadership, including Assistant Attorney General Jonathan Kanter, is typically the last step before officials decide whether to file a lawsuit. It’s often referred to as a “last-rites” meeting.

Officials could let UnitedHealth’s $3.3 billion purchase of Amedisys go through, potentially with some changes to address competition concerns. The timing ...